Quantitative Investment Management, LLC Incyte Corp Transaction History

Quantitative Investment Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$51.18 - $63.75 $854,552 - $1.06 Million	16,697 New	16,697 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$67.18 - $84.11 $902,764 - $1.13 Million	13,438 New	13,438 $1.08 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $1.09 Million - $1.37 Million	-16,510 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $1.09 Million - $1.32 Million	16,510 New	16,510 $1.31 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $410,509 - $502,271	-5,978 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$79.87 - $87.53 $477,462 - $523,254	5,978 New	5,978 $502,000
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $4.89 Million - $6.31 Million	-57,540 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $4.27 Million - $6.27 Million	57,540 New	57,540 $5.98 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $14.5 Million - $19.7 Million	-229,181 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $16.7 Million - $21.9 Million	229,181 New	229,181 $20 Million
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $5.9 Million - $7.01 Million	-81,020 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $2.65 Million - $3.19 Million	36,020 Added 80.04%	81,020 $6.88 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $2.86 Million - $3.97 Million	45,000 New	45,000 $3.87 Million
Q4 2018 Feb 12, 2019	SELL	$58.5 - $69.94 $696,150 - $832,286	-11,900 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $734,825 - $883,337	11,900 New	11,900 $822,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Investment Management, LLC with notifications on news.